4.8 Article

MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway

期刊

CANCER CELL
卷 39, 期 1, 页码 109-+

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2020.11.004

关键词

-

资金

  1. Cancer Prevention & Research Institute of Texas (CPRIT), United States [RR160101, RR150072, RP180725]
  2. National Institutes of Health, United States [CA092584, CA162804, GM047251]
  3. Southland Financial Corporation Distinguished Chair in Geriatrics Research

向作者/读者索取更多资源

This study revealed that loss of MutLa subunit MLH1 leads to production of neoantigens and activation of the cGAS-STING pathway, affecting DNA repair process and ultimately causing chromosomal abnormalities and DNA release. This unknown MMR mechanism has significant implications for genome stability and cancer therapy.
Tumors with defective mismatch repair (dMMR) are responsive to immunotherapy because of dMMR-induced neoantigens and activation of the cGAS-STING pathway. While neoantigens result from the hyper-mutable nature of dMMR, it is unknown how dMMR activates the cGAS-STING pathway. We show here that loss of the MutLa subunit MLH1, whose defect is responsible for similar to 50% of dMMR cancers, results in loss of MutLa-specific regulation of exonuclease 1 (Exo1) during DNA repair. This leads to unrestrained DNA excision by Exo1, which causes increased single-strand DNA formation, RPA exhaustion, DNA breaks, and aberrant DNA repair intermediates. Ultimately, this generates chromosomal abnormalities and the release of nuclear DNA into the cytoplasm, activating the cGAS-STING pathway. In this study, we discovered a hitherto unknown MMR mechanism that modulates genome stability and has implications for cancer therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据